Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Tanaka, Ryuichi; Matsuda, Sumio*; Watanabe, Hiroshi; Naramoto, Hiroshi
Koatsu Gasu, 31(10), p.754 - 776, 1994/00
no abstracts in English
Tanaka, Ryuichi
Hoshasen To Sangyo, (52), p.34 - 39, 1991/12
no abstracts in English
Tanaka, Ryuichi
Nihon Genshiryoku Gakkai-Shi, 33(11), p.1018 - 1023, 1991/11
no abstracts in English
Tanaka, Ryuichi
Proceedings of 4th China-Japan Joint Symposium on Accelerators for Nuclear Science and their Applications, p.127 - 130, 1991/00
no abstracts in English
Washiyama, Koshin*; Amano, Ryohei*; Maeda, Eita*; Yokoyama, Akihiko*; Nishinaka, Ichiro; Takahashi, Naruto*; Shinohara, Atsushi*; Watanabe, Shigeki; Ishioka, Noriko
no journal, ,
In order to use of an alpha emitter for targeted alpha therapy, we have started the production and the utilization of At using 30 MeV He particle in the Bi(He, 2n)At nuclear reaction at cyclotron facilities of Osaka University and JAEA Takasaki. In addition to that, we have been developing a Rn/At generator to expand the availability of At to wide range of populations far away from cyclotron facilities. The results of studies on the At-chemistry for clinical use and on the development of the Rn/At generator will be presented. And a review of current status of targeted alpha therapy in Japan will be also introduced.